527 related articles for article (PubMed ID: 10833090)
21. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Gisbert JP; Marcos S; Gisbert JL; Pajares JM
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055
[TBL] [Abstract][Full Text] [Related]
22. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J
Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
Veldhuyzen van Zanten S; Chiba N; Barkun A; Fallone C; Farley A; Cockeram A; Dallaire C; Simms L; Nicholls B
Can J Gastroenterol; 2003 Sep; 17(9):533-8. PubMed ID: 14532926
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer.
Labenz J; Tillenburg B; Weismüller J; Lütke A; Stolte M
Aliment Pharmacol Ther; 1997 Feb; 11(1):95-100. PubMed ID: 9042979
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
[TBL] [Abstract][Full Text] [Related]
26. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
Cammarota G; Cannizzaro O; Ojetti V; Cianci R; Pastorelli A; Armuzzi A; Gentiloni N; Gasbarrini A; Pirozzi G; Gasbarrini G
Aliment Pharmacol Ther; 2000 Jan; 14(1):73-7. PubMed ID: 10632648
[TBL] [Abstract][Full Text] [Related]
27. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
Boixeda D; Martín De Argila C; Bermejo F; López Sanromán A; Hernández Ranz F; García Plaza A
Rev Esp Enferm Dig; 2003 Mar; 95(3):206-9, 202-5. PubMed ID: 12760710
[TBL] [Abstract][Full Text] [Related]
28. Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
Pozzato P; Zagari M; Cardelli A; Catalano FA; Giglio A; Lami F; Pilotto A; Scarpulla G; Spadaccini A; Susi D; Tosatto R; Olivieri A; Bazzoli F; Roda E
Aliment Pharmacol Ther; 1998 May; 12(5):447-51. PubMed ID: 9663724
[TBL] [Abstract][Full Text] [Related]
29. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
[TBL] [Abstract][Full Text] [Related]
30. Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
Ellenrieder V; Fensterer H; Waurick M; Adler G; Glasbrenner B
Aliment Pharmacol Ther; 1998 Jul; 12(7):613-8. PubMed ID: 9701524
[TBL] [Abstract][Full Text] [Related]
31. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects.
Pilotto A; Di Mario F; Franceschi M; Leandro G; Battaglia G; Germanà B; Marin R; Valerio G
Aliment Pharmacol Ther; 2000 Aug; 14(8):1077-82. PubMed ID: 10930903
[TBL] [Abstract][Full Text] [Related]
32. One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Hung WK; Wong WM; Wong GS; Yip AW; Szeto ML; Lai KC; Hu WH; Chan CK; Xia HH; Yuen MF; Fung FM; Tong TS; Ho VY; Lam SK; Wong BC
Aliment Pharmacol Ther; 2002 Dec; 16(12):2067-72. PubMed ID: 12452939
[TBL] [Abstract][Full Text] [Related]
33. Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients.
Pazzi P; Scagliarini R; Gamberini S; Matarese V; Rizzo C; Gullini S
Aliment Pharmacol Ther; 1998 Aug; 12(8):731-4. PubMed ID: 9726385
[TBL] [Abstract][Full Text] [Related]
34. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
35. The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.
Sivri B; Simsek I; Hulagu S; Kadayifci A; Tozun N; Akarsu M; Uraz S; Savas MC; Koruk M; Bozbas A
Curr Med Res Opin; 2004 Aug; 20(8):1301-7. PubMed ID: 15324533
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
Ricciardiello L; Cannizzaro O; D'Angelo A; Ederle A; Gerace G; Iaquinto G; Reina G; Scarpulla G; Spadaccini A; Olivieri A; Tosatto R; Fossi S; Pozzato P; Zagari M; Bazzoli F; Roda E
Aliment Pharmacol Ther; 1998 Jun; 12(6):533-7. PubMed ID: 9678812
[TBL] [Abstract][Full Text] [Related]
37. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G
Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813
[TBL] [Abstract][Full Text] [Related]
38. Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
Marchi S; Costa F; Bellini M; Belcari C; Mumolo MG; Tornar A; Spisni R; Torelli E; Maltinti G
Eur J Gastroenterol Hepatol; 2001 May; 13(5):547-50. PubMed ID: 11396535
[TBL] [Abstract][Full Text] [Related]
39. Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Perri F; Villani MR; Quitadamo M; Annese V; Niro GA; Andriulli A
Aliment Pharmacol Ther; 2001 Jul; 15(7):1017-22. PubMed ID: 11421877
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
